Cervical cancer can be prevented! Its cause is known: HPV (human papillomavirus). HPV is a common sexually transmitted virus that doesn’t normally cause problems. But in some women, the infection persists over a long period of time and causes abnormal cells to form, which can develop into cervical cancer. HPV testing identifies women with the high-risk HPV infections that can cause cervical cancer, enabling diagnosis and treatment to be put in place before cervical cancer develops. The digene HPV Test is approved in the United States for use together with a Pap in women 30 and older. HPV testing is recommended by medical groups including American College of Obstetricians and Gynecologists, the American Cancer Society and the Association of Reproductive Health Professionals. More than 40 million tests for cancer-causing HPV have been performed with the digene HPV Test.
Take an active role in cervical cancer prevention. If you are age 30+, ask your doctor for an HPV test together with your Pap test.
Learn more about HPV by visiting www.theHPVtest.com. This educational site developed for women offers:
•Specific information for women over 30 and women under 30, so that your cervical cancer screening can be appropriately customized
•An interactive chart explaining what different Pap and HPV test results mean, and what expected follow-up might be
•A glossary of commonly-used medical terms related to gynecologic health, Pap and HPV testing
•An interactive “myths/facts” quiz – a fun way to learn about cervical cancer and HPV
•A conversational video summary of key information
•An Clinician Finder resource to help you locate health care providers in your community that screen women using the Pap + HPV test in women 30 and older
QIAGEN, developer and manufacturer of the digene HPV Test, is a leading global provider of sample and assay technologies. Sample technologies isolate DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies make these biomolecules visible for analysis and testing. QIAGEN provides more than 500 products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's offerings include one of the broadest panels of molecular diagnostic tests available worldwide, including the digene HPV Test to detect the high-risk types of human papillomavirus (HPV) that cause cervical cancer. QIAGEN employs more than 3,200 people in over 30 locations worldwide. For further information, visit www.qiagen.com.
Educational Brochures On Cervical Cancer Prevention:
Tools To Educate Others About Cervical Cancer Prevention:
Conversations About Cervical Cancer Prevention:
Track Your Test Results: